Peter J Mannon

Phone402-559-6209

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Peter J Mannon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

The Immune Basis For The Gastrointestinal Complications
Mannon, P. J.
Project: Research project
Granulocyte Colony Stimulating Factor Treatment For Croh
Mannon, P. J.
Project: Research project
Ulcerative Colitis - Regulation of the IL-13 Receptor System
Mannon, P. J.
Project: Research project
Ulcerative Colitis - Regulation of the IL-13 Receptor System
Mannon, P. J.
Project: Research project
Study Of Human Monoclonal Antibody To Il-12 For Treatmen
Mannon, P. J.
Project: Research project

66 Article
4 Chapter
4 Review article
3 Comment/debate
More

Celiac disease and the surgeon
Thompson, J. S. & Mannon, P., Jul 2022, In: American journal of surgery. 224, 1, p. 332-338 7 p.
Research output: Contribution to journal › Review article › peer-review
Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset
Morgan, N. N., Duck, L. W., Wu, J., Rujani, M., Thomes, P. G., Elson, C. O. & Mannon, P. J., Dec 1 2022, In: Inflammatory Bowel Diseases. 28, 12, p. 1893-1903 11 p.
Research output: Contribution to journal › Article › peer-review
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
HICKORY Study Group, Feb 2022, In: The Lancet Gastroenterology and Hepatology. 7, 2, p. 128-140 13 p.
Research output: Contribution to journal › Article › peer-review
26 Scopus citations
Gut microbial biomarkers for predicting adverse outcomes in people with chronic kidney disease
Cooper, T. E., Au, E. H., Chung, E. Y. M., Tunnicliffe, D. J., Craig, J. C., Gesualdo, L., Howell, M., Mannon, P., Mannon, R., Strippoli, G. F. M., Teixeira-Pinto, A., Tong, A. & Wong, G., Jan 12 2022, In: Cochrane Database of Systematic Reviews. 2022, 1, CD014786.
Research output: Contribution to journal › Article › peer-review
CD4⁺ T cell activation and concomitant mTOR metabolic inhibition can ablate microbiota-specific memory cells and prevent colitis
Zhao, Q., Duck, L. W., Huang, F., Alexander, K. L., Maynard, C. L., Mannon, P. J. & Elson, C. O., Dec 23 2021, In: Science immunology. 5, 54, eabc6373.
Research output: Contribution to journal › Article › peer-review
14 Scopus citations

Peter J Mannon, MD

Fingerprint

Network

Dive into details

The Immune Basis For The Gastrointestinal Complications

Granulocyte Colony Stimulating Factor Treatment For Croh

Ulcerative Colitis - Regulation of the IL-13 Receptor System

Ulcerative Colitis - Regulation of the IL-13 Receptor System

Study Of Human Monoclonal Antibody To Il-12 For Treatmen

Celiac disease and the surgeon

Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Gut microbial biomarkers for predicting adverse outcomes in people with chronic kidney disease

CD4⁺ T cell activation and concomitant mTOR metabolic inhibition can ablate microbiota-specific memory cells and prevent colitis

Peter J Mannon, MD

Fingerprint

Network

Projects

Research output